1. Home
  2. SRPT vs ARCB Comparison

SRPT vs ARCB Comparison

Compare SRPT & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • ARCB
  • Stock Information
  • Founded
  • SRPT 1980
  • ARCB 1923
  • Country
  • SRPT United States
  • ARCB United States
  • Employees
  • SRPT N/A
  • ARCB N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • ARCB Trucking Freight/Courier Services
  • Sector
  • SRPT Health Care
  • ARCB Industrials
  • Exchange
  • SRPT Nasdaq
  • ARCB Nasdaq
  • Market Cap
  • SRPT 1.7B
  • ARCB 1.7B
  • IPO Year
  • SRPT 1997
  • ARCB N/A
  • Fundamental
  • Price
  • SRPT $21.70
  • ARCB $72.42
  • Analyst Decision
  • SRPT Hold
  • ARCB Buy
  • Analyst Count
  • SRPT 29
  • ARCB 13
  • Target Price
  • SRPT $46.15
  • ARCB $93.50
  • AVG Volume (30 Days)
  • SRPT 22.8M
  • ARCB 411.6K
  • Earning Date
  • SRPT 08-06-2025
  • ARCB 07-30-2025
  • Dividend Yield
  • SRPT N/A
  • ARCB 0.65%
  • EPS Growth
  • SRPT N/A
  • ARCB 27.88
  • EPS
  • SRPT N/A
  • ARCB 6.77
  • Revenue
  • SRPT $2,481,531,000.00
  • ARCB $4,054,102,000.00
  • Revenue This Year
  • SRPT $3.52
  • ARCB $0.10
  • Revenue Next Year
  • SRPT N/A
  • ARCB $6.48
  • P/E Ratio
  • SRPT N/A
  • ARCB $10.83
  • Revenue Growth
  • SRPT 64.89
  • ARCB N/A
  • 52 Week Low
  • SRPT $10.42
  • ARCB $55.19
  • 52 Week High
  • SRPT $144.22
  • ARCB $123.26
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 57.32
  • ARCB 47.76
  • Support Level
  • SRPT $17.28
  • ARCB $67.90
  • Resistance Level
  • SRPT $20.61
  • ARCB $75.50
  • Average True Range (ATR)
  • SRPT 1.51
  • ARCB 3.21
  • MACD
  • SRPT 0.96
  • ARCB -0.33
  • Stochastic Oscillator
  • SRPT 95.91
  • ARCB 34.72

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: